🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Medtronic PLC (2M6)

Xetra
Currency in EUR
79.39
-0.36(-0.45%)
Closed

2M6 Income Statement

Advanced Income Statement
Period Ending:
2015
24/04
2016
29/04
2017
28/04
2018
27/04
2019
26/04
2020
24/04
2021
30/04
2022
29/04
2023
28/04
2024
26/04
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa28,91330,11731,68631,22732,364
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-5.38%+4.16%+5.21%-1.45%+3.64%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa9,26910,35510,02810,62211,091
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa19,64419,76221,65820,60521,273
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-8.6%+0.6%+9.59%-4.86%+3.24%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa67.94%65.62%68.35%65.98%65.73%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa14,48214,27214,81114,82714,864
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-2.04%-1.45%+3.78%+0.11%+0.25%
aa.aaaa.aaaa.aaaa.aaaa.aa2,3312,4932,7462,6962,735
aa.aaaa.aaaa.aaaa.aaaa.aa9,8829,95610,04710,00410,183
aa.aaaa.aaaa.aaaa.aaaa.aa51340285429253
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa5,1625,4906,8475,7786,409
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-23.06%+6.35%+24.72%-15.61%+10.92%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa17.85%18.23%21.61%18.5%19.8%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-1,092-925-367-197-122
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+24.38%+15.29%+60.32%+46.32%+38.07%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-1,092-925-553-583-719
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa--186386597
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa787110234740-117
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa4,8574,6756,7146,3216,170
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa----75-
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-348-163-951-167
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa4,0553,8955,5175,3644,837
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-21.97%-3.95%+41.64%-2.77%-9.82%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa14.02%12.93%17.41%17.18%14.95%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa-7512654561,5801,133
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa4,8063,6305,0613,7843,704
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-17-24-22-26-28
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa4,7893,6065,0393,7583,676
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+3.41%-24.7%+39.74%-25.42%-2.18%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa16.56%11.97%15.9%12.03%11.36%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa4,7893,6065,0393,7583,676
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa3.572.683.752.832.77
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+3.85%-24.94%+40%-24.72%-2.03%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa3.542.663.732.822.76
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+3.81%-24.86%+40.23%-24.4%-2.13%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa1,340.71,344.91,342.41,329.81,327.7
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa1,351.11,3541,351.41,332.81,330.2
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa2.162.322.522.722.76
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+8%+7.41%+8.62%+7.94%+1.47%
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa7,8258,1929,5548,4759,056
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-16.47%+4.69%+16.63%-11.29%+6.86%
EBITDA Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa27.06%27.2%30.15%27.14%27.98%
EBIT